Share-based Payment Arrangement, Expense of LIFECORE BIOMEDICAL, INC. \DE\ from 28 Aug 2011 to 25 May 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 28 Aug 2011 to 25 May 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Share-based Payment Arrangement, Expense for the quarter ending 24 Nov 2024 was $3,372,000, a 114% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ Share-based Payment Arrangement, Expense for the twelve months ending 24 Nov 2024 was $8,882,000, a 84% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Share-based Payment Arrangement, Expense for 2024 was $10,158,000, a 64% increase from 2023.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Share-based Payment Arrangement, Expense for 2023 was $6,201,000, a 72% increase from 2022.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Share-based Payment Arrangement, Expense for 2022 was $3,612,000, a 38% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,158,000 +$3,957,000 +64% 27 May 2024 25 May 2025 10-K 07 Aug 2025 2025 FY
2023 $6,201,000 +$2,589,000 +72% 29 May 2023 26 May 2024 10-K 07 Aug 2025 2025 FY
2022 $3,612,000 +$1,004,000 +38% 30 May 2022 28 May 2023 10-K 26 Aug 2024 2024 FY
2021 $2,608,000 -$752,000 -22% 31 May 2021 29 May 2022 10-K 26 Aug 2024 2024 FY
2020 $3,360,000 +$941,000 +39% 01 Jun 2020 30 May 2021 10-K 20 Mar 2024 2023 FY
2019 $2,419,000 -$1,141,000 -32% 27 May 2019 31 May 2020 10-K/A 16 Mar 2023 2022 FY
2018 $3,560,000 -$843,000 -19% 28 May 2018 26 May 2019 10-K 29 Jul 2021 2021 FY
2017 $4,403,000 +$439,000 +11% 29 May 2017 27 May 2018 10-K 14 Aug 2020 2020 FY
2016 $3,964,000 +$499,000 +14% 30 May 2016 28 May 2017 10-K 01 Aug 2019 2019 FY
2015 $3,465,000 +$1,888,000 +120% 01 Jun 2015 29 May 2016 10-K 09 Aug 2018 2018 FY
2014 $1,577,000 +$221,000 +16% 26 May 2014 31 May 2015 10-K/A 15 Mar 2018 2017 FY
2013 $1,356,000 -$339,000 -20% 27 May 2013 25 May 2014 10-K 01 Aug 2016 2016 FY
2012 $1,695,000 -$177,000 -9.5% 28 May 2012 26 May 2013 10-K 31 Jul 2015 2015 FY
2011 $1,872,000 30 May 2011 27 May 2012 10-K 01 Aug 2014 2014 FY

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $8,882,000 $3,372,000 +$1,795,000 +114% 26 Aug 2024 24 Nov 2024 10-Q 02 Jan 2025 2025 Q2
Q3 2024 $7,087,000 $2,419,000 +$886,000 +58% 27 May 2024 25 Aug 2024 10-Q 04 Oct 2024 2025 Q1
Q2 2024 $6,201,000 $1,597,000 +$785,000 +97% 26 Feb 2024 26 May 2024 10-K 07 Aug 2025 2025 FY
Q1 2024 $5,416,000 $1,494,000 +$591,000 +65% 27 Nov 2023 25 Feb 2024 10-Q 09 Aug 2024 2024 Q3
Q4 2023 $4,825,000 $1,577,000 +$465,000 +42% 28 Aug 2023 26 Nov 2023 10-Q 02 Jan 2025 2025 Q2
Q3 2023 $4,360,000 $1,533,000 +$748,000 +95% 29 May 2023 27 Aug 2023 10-Q 04 Oct 2024 2025 Q1
Q2 2023 $3,612,000 $812,000 +$132,000 +19% 27 Feb 2023 28 May 2023 10-K 26 Aug 2024 2024 FY
Q1 2023 $3,480,000 $903,000 +$281,000 +45% 28 Nov 2022 26 Feb 2023 10-Q 09 Aug 2024 2024 Q3
Q4 2022 $3,199,000 $1,112,000 +$426,000 +62% 29 Aug 2022 27 Nov 2022 10-Q 09 Aug 2024 2024 Q2
Q3 2022 $2,773,000 $785,000 +$165,000 +27% 30 May 2022 28 Aug 2022 10-Q 09 Aug 2024 2024 Q1
Q2 2022 $2,608,000 $680,000 -$99,000 -13% 28 Feb 2022 29 May 2022 10-K 26 Aug 2024 2024 FY
Q1 2022 $2,707,000 $622,000 -$175,000 -22% 29 Nov 2021 27 Feb 2022 10-Q 02 Jun 2023 2023 Q3
Q4 2021 $2,882,000 $686,000 -$206,000 -23% 30 Aug 2021 28 Nov 2021 10-Q 16 Mar 2023 2023 Q2
Q3 2021 $3,088,000 $620,000 -$272,000 -30% 31 May 2021 29 Aug 2021 10-Q/A 16 Mar 2023 2022 Q1
Q2 2021 $3,360,000 $779,000 +$241,000 +45% 01 Mar 2021 30 May 2021 10-K 20 Mar 2024 2023 FY
Q1 2021 $3,119,000 $797,000 +$231,000 +41% 30 Nov 2020 28 Feb 2021 10-Q 07 Apr 2022 2022 Q3
Q4 2020 $2,888,000 $892,000 +$105,000 +13% 31 Aug 2020 29 Nov 2020 10-Q 07 Jan 2022 2022 Q2
Q3 2020 $2,783,000 $892,000 +$364,000 +69% 01 Jun 2020 30 Aug 2020 10-Q 05 Oct 2021 2022 Q1
Q2 2020 $2,419,000 $538,000 -$540,000 -50% 24 Feb 2020 31 May 2020 10-K/A 16 Mar 2023 2022 FY
Q1 2020 $2,959,000 $566,000 -$250,000 -31% 25 Nov 2019 23 Feb 2020 10-Q 08 Apr 2021 2021 Q3
Q4 2019 $3,209,000 $787,000 -$151,000 -16% 26 Aug 2019 24 Nov 2019 10-Q 07 Jan 2021 2021 Q2
Q3 2019 $3,360,000 $528,000 -$200,000 -27% 27 May 2019 25 Aug 2019 10-Q 07 Oct 2020 2021 Q1
Q2 2019 $3,560,000 $1,078,000 -$112,000 -9.4% 25 Feb 2019 26 May 2019 10-K 29 Jul 2021 2021 FY
Q1 2019 $3,672,000 $816,000 -$331,000 -29% 26 Nov 2018 24 Feb 2019 10-Q 03 Apr 2020 2020 Q3
Q4 2018 $4,003,000 $938,000 -$178,000 -16% 27 Aug 2018 25 Nov 2018 10-Q 02 Jan 2020 2020 Q2
Q3 2018 $4,181,000 $728,000 -$222,000 -23% 28 May 2018 26 Aug 2018 10-Q 03 Oct 2019 2020 Q1
Q2 2018 $4,403,000 $1,190,000 +$68,000 +6.1% 26 Feb 2018 27 May 2018 10-K 14 Aug 2020 2020 FY
Q1 2018 $4,335,000 $1,147,000 +$78,000 +7.3% 27 Nov 2017 25 Feb 2018 10-Q 04 Apr 2019 2019 Q3
Q4 2017 $4,257,000 $1,116,000 +$150,000 +16% 28 Aug 2017 26 Nov 2017 10-Q 07 Jan 2019 2019 Q2
Q3 2017 $4,107,000 $950,000 +$143,000 +18% 29 May 2017 27 Aug 2017 10-Q 05 Oct 2018 2019 Q1
Q2 2017 $3,964,000 $1,122,000 +$238,000 +27% 27 Feb 2017 28 May 2017 10-K 01 Aug 2019 2019 FY
Q1 2017 $3,726,000 $1,069,000 +$185,000 +21% 28 Nov 2016 26 Feb 2017 10-Q 05 Apr 2018 2018 Q3
Q4 2016 $3,541,000 $966,000 +$66,000 +7.3% 29 Aug 2016 27 Nov 2016 10-Q 05 Jan 2018 2018 Q2
Q3 2016 $3,475,000 $807,000 +$10,000 +1.3% 30 May 2016 28 Aug 2016 10-Q 28 Sep 2017 2018 Q1
Q2 2016 $3,465,000 $884,000 +$350,096,000 29 Feb 2016 29 May 2016 10-K 09 Aug 2018 2018 FY
Q1 2016 $346,631,000 $884,000 +$493,000 +126% 29 Nov 2015 28 Feb 2016 10-Q 07 Apr 2017 2017 Q3
Q4 2015 $347,124,000 $900,000 -$349,100,000 -100% 31 Aug 2015 29 Nov 2015 10-Q 05 Jan 2017 2017 Q2
Q3 2015 $1,976,000 $797,000 +$399,000 +100% 01 Jun 2015 30 Aug 2015 10-Q 29 Sep 2016 2017 Q1
Q2 2015 $1,577,000 $349,212,000 +$363,710,000 +51% 02 Mar 2015 31 May 2015 10-K/A 15 Mar 2018 2017 FY
Q1 2015 $362,133,000 $391,000 -$352,609,000 -100% 01 Dec 2014 01 Mar 2015 10-Q 30 Mar 2016 2016 Q3
Q4 2014 $9,524,000 $350,000,000 -$11,000,000 -3% 30 Aug 2014 30 Nov 2014 10-Q 07 Jan 2016 2016 Q2
Q3 2014 $1,476,000 $398,000 +$120,000 +43% 02 Jun 2014 31 Aug 2014 10-Q 01 Oct 2015 2016 Q1
Q2 2014 $1,356,000 $712,922,000 -$713,482,000 -127408% 24 Feb 2014 25 May 2014 10-K 01 Aug 2016 2016 FY
Q1 2014 $714,838,000 $353,000,000 +$352,536,000 +75978% 25 Nov 2013 23 Feb 2014 10-Q 02 Apr 2015 2015 Q3
Q4 2013 $362,302,000 $361,000,000 +$360,677,000 +111665% 26 Aug 2013 24 Nov 2013 10-Q 09 Jan 2015 2015 Q2
Q3 2013 $1,625,000 $278,000 -$70,000 -20% 27 May 2013 25 Aug 2013 10-Q 08 Oct 2014 2015 Q1
Q2 2013 $1,695,000 $560,000 +$884,117,000 25 Feb 2013 26 May 2013 10-K 31 Jul 2015 2015 FY
Q1 2013 $882,422,000 $464,000 +$35,000 +8.2% 26 Nov 2012 24 Feb 2013 10-Q 28 Mar 2014 2014 Q3
Q4 2012 $882,457,000 $323,000 -$443,677,000 -100% 27 Aug 2012 25 Nov 2012 10-Q 03 Jan 2014 2014 Q2
Q3 2012 $438,780,000 $348,000 -$440,652,000 -100% 28 May 2012 26 Aug 2012 10-Q 26 Sep 2013 2014 Q1
Q2 2012 $1,872,000 $883,557,000 27 Feb 2012 27 May 2012 10-K 01 Aug 2014 2014 FY
Q1 2012 $429,000 28 Nov 2011 26 Feb 2012 10-Q 04 Apr 2013 2013 Q3
Q4 2011 $444,000,000 29 Aug 2011 27 Nov 2011 10-Q 04 Jan 2013 2013 Q2
Q3 2011 $441,000,000 28 May 2011 28 Aug 2011 10-Q/A 02 Jan 2013 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.